FDA
approval
· 2023-07-31
FDA Approved: ARGATROBAN — Original Application (Mullan Pharmaceutical Inc.)
Summary
The FDA approved a generic version of argatroban from Mullan Pharmaceutical Inc. for anticoagulation in patients with heparin-induced thrombocytopenia.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for ARGATROBAN (ARGATROBAN)